These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37818522)

  • 1. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women.
    Keerti A; Madke B; Keerti A; Lopez MJC; Lirio FS
    Cureus; 2023 Sep; 15(9):e44949. PubMed ID: 37818522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
    Lee SW; Juhasz M; Mobasher P; Ekelem C; Mesinkovska NA
    J Drugs Dermatol; 2018 Apr; 17(4):457-463. PubMed ID: 29601622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
    Gupta AK; Talukder M
    J Cosmet Dermatol; 2022 May; 21(5):1841-1848. PubMed ID: 35238144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's New in Therapy for Male Androgenetic Alopecia?
    Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
    Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
    Nobari NN; Roohaninasab M; Sadeghzadeh-Bazargan A; Goodarzi A; Behrangi E; Nikkhah F; Ghassemi M
    Adv Clin Exp Med; 2023 Jul; 32(7):813-823. PubMed ID: 36897103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
    Nestor MS; Ablon G; Gade A; Han H; Fischer DL
    J Cosmet Dermatol; 2021 Dec; 20(12):3759-3781. PubMed ID: 34741573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
    Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
    J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
    Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
    J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of androgenetic alopecia.
    Bolduc C; Shapiro J
    Am J Clin Dermatol; 2000; 1(3):151-8. PubMed ID: 11702296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Chen L; Zhang J; Wang L; Wang H; Chen B
    Aesthetic Plast Surg; 2020 Jun; 44(3):962-970. PubMed ID: 32166351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 20. Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature.
    Ocampo-Garza SS; Fabbrocini G; Ocampo-Candiani J; Cinelli E; Villani A
    Dermatol Ther; 2020 Nov; 33(6):e14267. PubMed ID: 32882083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.